Foot and ankle soft tissue sarcomas (STSs) are rare neoplasms associated with a high risk of local recurrence and metastasis. Although amputation is often performed, its impact on prognosis remains unknown. The aims of our systematic review were identifying risk factors for (1) disease-specific death, (2) local recurrence, (3) metastasis, and assessing (4) whether the type of surgery (amputation or limb-salvage) affected disease-specific survival.
Methods:
This systematic review was conducted following PRISMA guidelines. The PubMed, Embase, and Scopus databases were searched. Our study was registered in PROSPERO (ID: 415624). Quality appraisal was done using STROBE guidelines.
Results:
A total of 7 studies and 123 patients were included. Metastasis was the only risk factor for disease-specific death (OR = 107.85, P< .001). Previous unplanned excision (OR = 22.29, P= .009) and positive margins (OR = 64.48, P= .011) were associated with higher risk of local recurrence. Patients with high-grade tumors (OR = 13.22, P= .023) and tumors ≥6 cm (OR = 7.40, P= .022) were more likely to develop metastases. After adjusting for confounders (age, sex, and presence of metastasis), amputation was not associated with poorer disease-specific survival.
Conclusion:
Metastasis was the single most important risk factor for death with foot and ankle soft tissue sarcoma. Positive margins and history of previous unplanned excision are risk factors for local recurrence. The most important risk factors for metastasis are tumor grade and size ≥6 cm. Amputation was not associated with poorer disease-specific survival.
BaysalÖSağlamFSofuluÖYiğitOŞirinEErolB. Indications of amputation after limb-salvage surgery of patients with extremity-located bone and soft-tissue sarcomas: a retrospective clinical study. Acta Orthop Traumatol Turc. 2021;55(2):154-158. doi:10.5152/j.aott.2021.20115
2.
BerlinSJ.Statistical analysis of 307,601 tumors and other lesions of the foot. J Am Podiatr Med Assoc. 1995;85(11):699-703. doi:10.7547/87507315-85-11-699
3.
Bryce-AlbertiMGonzalezMRQuevedo-RamirezAPretell-MazziniJ.Squamous cell carcinoma arising from chronic osteomyelitis in the extremities: treatment approach and oncological outcomes-a systematic review of the literature. J Skin Cancer. 2022;2022:2671420. doi:10.1155/2022/2671420
4.
ChouLBHoYYMalawerMM.Tumors of the foot and ankle: experience with 153 cases. Foot Ankle Int. 2009;30(9):836-841. doi:10.3113/fai.2009.0836
5.
CollinCGodboldJHajduSBrennanM.Localized extremity soft tissue sarcoma: an analysis of factors affecting survival. J Clin Oncol. 1987;5(4):601-612. doi:10.1200/jco.1987.5.4.601
6.
CribbGLLooSCDickinsonI.Limb salvage for soft-tissue sarcomas of the foot and ankle. J Bone Joint Surg Br. 2010;92(3):424-429. doi:10.1302/0301-620x.92b3.22331
7.
DemetriGDBakerLHBeechD, et al. Soft tissue sarcoma clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2005;3(2):158-194.
8.
ElmEvAltmanDGEggerM, et al. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335(7624):806-808. doi:10.1136/bmj.39335.541782.AD
9.
GibbsJFHuangPPLeeRJ, et al. Malignant fibrous histiocytoma: an institutional review. Cancer Invest. 2001;19(1):23-27. doi:10.1081/cnv-100000071
10.
GilbertNFCannonCPLinPPLewisVO.Soft-tissue sarcoma. J Am Acad Orthop Surg. 2009;17(1):40-47. doi:10.5435/00124635-200901000-00006
11.
GonzalezMRBediADSKarczewskiDLozano-CalderonSA.Treatment and outcomes of fungal prosthetic joint infections: a systematic review of 225 cases. J Arthroplasty. Published online May 10, 2023. doi:10.1016/j.arth.2023.05.003
12.
GonzalezMRCastillo-FloresSPortmann-BaraccoAPretell-MazziniJ.Ganglion cysts arising from the proximal tibiofibular joint: treatment approach and associated outcomes—a systematic review. HSS Journal. Published online May 21, 2023. doi:10.1177/15563316231172510
13.
GonzalezMRClunkMJBediADS, et al. Prognostic and predictive factors in undifferentiated pleomorphic sarcoma: a long-term study from a large tertiary care urban center. J Surg Oncol. 2023;128(2):322-331. doi:10.1002/jso.27279
14.
GrimerRJ.Size matters for sarcomas!Ann R Coll Surg Engl. 2006;88(6):519-524. doi:10.1308/003588406x130651
15.
GronchiALo VulloSColomboC, et al. Extremity soft tissue sarcoma in a series of patients treated at a single institution: local control directly impacts survival. Ann Surg. 2010;251(3):506-511. doi:10.1097/SLA.0b013e3181cf87fa
16.
InchausteguiMLRuizKGonzalezMRPretell-MazziniJ.Surgical management of metastatic pathologic subtrochanteric fractures: treatment modalities and associated outcomes. JBJS Rev. 2023;11(5). doi:10.2106/jbjs.Rvw.22.00232
17.
JubbalKTD’SouzaGAbramsRAKulidjianAA.Management of soft tissue tumors of the upper extremity: a review. SICOT J. 2017;3:47. doi:10.1051/sicotj/2017001
18.
KaneuchiYYoshidaSFujiwaraTEvansSAbuduA.Limb salvage surgery has a higher complication rate than amputation but is still beneficial for patients younger than 10 years old with osteosarcoma of an extremity. J Pediatr Surg. 2022;57(11):702-709. doi:10.1016/j.jpedsurg.2022.04.001
19.
KarakousisCPDe YoungCDriscollDL.Soft tissue sarcomas of the hand and foot: management and survival. Ann Surg Oncol. 1998;5(3):238-240. doi:10.1007/bf02303779
20.
KheiranAEastleyNCHansonJRMcCullochTAAllenPEAshfordRU.The importance of the early appropriate management of foot and ankle soft tissue sarcomas – experiences of a regional sarcoma service. Foot (Edinb). 2022;50:101866. doi:10.1016/j.foot.2021.101866
21.
KirilovaMKleinALindnerLH, et al. Amputation for extremity sarcoma: indications and outcomes. Cancers (Basel). 2021;13(20):5125. doi:10.3390/cancers13205125
22.
KoulaxouzidisGSchwarzkopfEBannaschHStarkGB.Is revisional surgery mandatory when an unexpected sarcoma diagnosis is made following primary surgery?World J Surg Oncol. 2015;13:306. doi:10.1186/s12957-015-0719-y
23.
LattLDTurcotteREIslerMHWongC.Caseseries. Soft-tissue sarcoma of the foot. Can J Surg. 2010;53(6):424-431.
24.
LiRHZhouQLiABZhangHZLinZQ.A nomogram to predict metastasis of soft tissue sarcoma of the extremities. Medicine (Baltimore). 2020;99(21):e20165. doi:10.1097/md.0000000000020165
25.
LiangYGuoTHXuBS, et al. The impact of unplanned excision on the outcomes of patients with soft tissue sarcoma of the trunk and extremity: a propensity score matching analysis. Front Oncol. 2020;10:617590. doi:10.3389/fonc.2020.617590
26.
LochnerJMengeFVassosNHohenbergerPKasperB.Prognosis of patients with metastatic soft tissue sarcoma: advances in recent years. Oncol Res Treat. 2020;43(11):613-619. doi:10.1159/000509519
27.
MandardAMPetiotJFMarnayJ, et al. Prognostic factors in soft tissue sarcomas. A multivariate analysis of 109 cases. Cancer. 1989;63(7):1437-1451. doi:10.1002/1097-0142(19890401)63:7<1437::aid-cncr2820630735>3.0.co;2-q
28.
MendenhallWMIndelicatoDJScarboroughMT, et al. The management of adult soft tissue sarcomas. Am J Clin Oncol. 2009;32(4):436-442. doi:10.1097/COC.0b013e318173a54f
29.
MurrayDTopferJDecilveoAPWittigJC.Benefits associated with early diagnosis and treatment of soft tissue sarcomas of the foot and ankle. J Foot Ankle Surg. 2016;55(5):980-984. doi:10.1053/j.jfas.2016.05.001
30.
NishimuraAMatsumineAAsanumaK, et al. The adverse effect of an unplanned surgical excision of foot soft tissue sarcoma. World J Surg Oncol. 2011;9:160. doi:10.1186/1477-7819-9-160
31.
OzgerHEralpLTürkerMBasaranM.Surgical treatment of malignant tumors of the foot and ankle. Int J Clin Oncol. 2005;10(2):127-132. doi:10.1007/s10147-004-0470-9
32.
PotterBKAdamsSCPitcherJDJrTempleHT.Local recurrence of disease after unplanned excisions of high-grade soft tissue sarcomas. Clin Orthop Relat Res. 2008;466(12):3093-3100. doi:10.1007/s11999-008-0529-4
33.
Pretell-MazziniJBartonMDJrConwaySATempleHT.Unplanned excision of soft-tissue sarcomas: current concepts for management and prognosis. J Bone Joint Surg Am. 2015;97(7):597-603. doi:10.2106/jbjs.N.00649
34.
ReijersSJMHussonOSoomersV, et al. Health-related quality of life after isolated limb perfusion compared to extended resection, or amputation for locally advanced extremity sarcoma: is a limb salvage strategy worth the effort?Eur J Surg Oncol. 2022;48(3):500-507. doi:10.1016/j.ejso.2021.08.007
35.
RougraffBTLawrenceJDavisK.Length of symptoms before referral: prognostic variable for high-grade soft tissue sarcoma?Clin Orthop Relat Res. 2012;470(3):706-711. doi:10.1007/s11999-011-2192-4
36.
Rueten-BuddeAJvan PraagVMvan de SandeMAJFioccoM.Dynamic prediction of overall survival for patients with high-grade extremity soft tissue sarcoma. Surg Oncol. 2018;27(4):695-701. doi:10.1016/j.suronc.2018.09.003
37.
SalipasADowseyMMMayDChoongPF. ‘Beware the lump in the foot!’: predictors of recurrence and survival in bone and soft-tissue sarcomas of the foot and ankle. ANZ J Surg. 2014;84(7-8):533-538. doi:10.1111/ans.12593
38.
SawamuraCMatsumotoSShimojiTOkawaAAeK.How long should we follow patients with soft tissue sarcomas?Clin Orthop Relat Res. 2014;472(3):842-848. doi:10.1007/s11999-013-3076-6
39.
ScullySPTempleHTHarrelsonJM.Synovial sarcoma of the foot and ankle. Clin Orthop Relat Res. 1999;364:220-226. doi:10.1097/00003086-199907000-00028
40.
ShiuMHCastroEBHajduSIFortnerJG.Surgical treatment of 297 soft tissue sarcomas of the lower extremity. Ann Surg. 1975;182(5):597-602. doi:10.1097/00000658-197511000-00011
41.
SmithHGThomasJMSmithMJFHayesAJStraussDC.Major amputations for extremity soft-tissue sarcoma. Ann Surg Oncol. 2018;25(2):387-393. doi:10.1245/s10434-017-5895-2
42.
SugiuraHTsukushiSYoshidaMNishidaY.What is the success of repeat surgical treatment of a local recurrence after initial wide resection of soft tissue sarcomas?Clin Orthop Relat Res. 2018;476(9):1791-1800. doi:10.1007/s11999.0000000000000158
43.
TempleHTWormanDSMnaymnehWA.Unplanned surgical excision of tumors of the foot and ankle. Cancer Control. 2001;8(3):262-268. doi:10.1177/107327480100800306
44.
TrautmannFSchulerMSchmittJ.Burden of soft-tissue and bone sarcoma in routine care: estimation of incidence, prevalence and survival for health services research. Cancer Epidemiol. 2015;39(3):440-446. doi:10.1016/j.canep.2015.03.002
45.
VenkatesanMRichardsCJMcCullochTA, et al. Inadvertent surgical resection of soft tissue sarcomas. Eur J Surg Oncol. 2012;38(4):346-351. doi:10.1016/j.ejso.2011.12.011
46.
WilliardWCHajduSICasperESBrennanMF.Comparison of amputation with limb-sparing operations for adult soft tissue sarcoma of the extremity. Ann Surg. 1992;215(3):269-275. doi:10.1097/00000658-199203000-00012
47.
ZhangYWuZChangJ, et al. An updated incidence trends of soft-tissue sarcoma and cancer-specific survival of patients with primary soft-tissue sarcoma of liver: a population-based study. Expert Rev Gastroenterol Hepatol. 2021;15(6):689-698. doi:10.1080/17474124.2021.1842193
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
